ELECTROCORE

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The companyโs current indications are for the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.
ELECTROCORE
Industry:
Health Care Medical Device Therapeutics
Founded:
2005-01-01
Address:
Basking Ridge, New Jersey, United States
Country:
United States
Website Url:
http://www.electrocore.com
Total Employee:
11+
Status:
Active
Contact:
888-903-CORE
Email Addresses:
[email protected]
Total Funding:
145.46 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Altamira Therapeutics
Altamira Therapeutics develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
American Investment Holdings
American Investment Holdings investment in Series B - electroCore
Knoll Capital Management
Knoll Capital Management investment in Series B - electroCore
The Vinik Family Foundation
The Vinik Family Foundation investment in Series B - electroCore
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Series B - electroCore
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Series A - electroCore
Core Ventures
Core Ventures investment in Series A - electroCore
Easton Capital
Easton Capital investment in Series A - electroCore
Official Site Inspections
http://www.electrocore.com Semrush global rank: 2.12 M Semrush visits lastest month: 9.63 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "electroCore"
electroCore | Pioneers of Tech. Stimulators of Life.
ElectroCore is committed to the safety and care of our patients, providers, and employees during the COVID-19 pandemic. We have implemented several operational enhancements, research initiatives, and virtual capabilities to โฆSee details»
Our Leadership - electroCore
Joining electroCore in 2016, Lisa embarked on a journey marked by dedication and a commitment to enhancing customer experiences. As a seasoned electroCore veteran, Lisa has played โฆSee details»
electroCore - Wikipedia
ElectroCore, Inc. (Nasdaq: ECOR) is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles โฆSee details»
electroCore - Crunchbase Company Profile & Funding
Organization. electroCore . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... electroCore, Inc. โฆSee details»
electroCore Org Chart + Executive Team - The Official โฆ
Organizational Chart of electroCore. electroCore Org Chart www.electrocore.com. has 13 executives +1 888 903 2673; Add an executive. electroCore (ECOR) News . Anything missing? We search for you. Print or download CEO & โฆSee details»
electroCore - Org Chart, Teams, Culture & Jobs | The Org
View electroCore's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
electroCore, Inc. Company Profile | Rockaway, NJ | Competitors ...
Find company research, competitor information, contact details & financial data for electroCore, Inc. of Rockaway, NJ. Get the latest business insights from Dun & Bradstreet.See details»
ElectroCore Company Profile - Office Locations, Competitors
Oct 28, 2024 ElectroCore has 3 employees across 6 locations and $25.18 m in annual revenue in FY 2024. See insights on ElectroCore including office locations, competitors, revenue, โฆSee details»
ElectroCore Inc Company Profile - Overview - GlobalData
ElectroCore Inc (ElectroCore) is a bioelectronic medicine healthcare company. The company develops vagus nerve stimulation non-invasively (nVNS) therapy for neurology and โฆSee details»
Investor Relations | electroCore
Mar 12, 2025 ROCKAWAY, N.J. , April 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today that it will report financial results for the first โฆSee details»
Financial Information - electroCore
The Investor Relations website contains information about electroCore's business for stockholders, potential investors, and financial analysts.See details»
Contact Us - electroCore
ElectroCore is committed to the safety and care of our patients, providers, and employees during the COVID-19 pandemic. We have implemented several operational enhancements, research โฆSee details»
electroCore (ECOR) Company Profile & Description - Stock Analysis
Jun 22, 2018 electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (โnVNSโ) technology platform in the United โฆSee details»
Working At ElectroCore: Company Overview and Culture - Zippia
Learn about working at ElectroCore from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more. ... Organization Type. Public. Social Media. โฆSee details»
electroCore - Funding, Financials, Valuation & Investors
Their stock opened with $15.00 in its Jun 21, 2018 IPO. electroCore is funded by 6 investors. American Investment Holdings and Knoll Capital Management are the most recent investors. โฆSee details»
electroCore Completes Acquisition of NeuroMetrix, Gaining Access โฆ
Dec 17, 2024 About electroCore, Inc. electroCore, Inc. and its subsidiaries are a commercial stage bioelectronic technology company whose mission is to improve health and quality of life โฆSee details»
Our History - electroCore
ElectroCore is committed to the safety and care of our patients, providers, and employees during the COVID-19 pandemic. We have implemented several operational enhancements, research โฆSee details»
Earnings call transcript: ElectroCoreโs Q1 2025 revenue climbs 23% ...
1 day ago ElectroCore reported a notable 23% increase in revenue for Q1 2025, reaching $6.7 million. This continues the companyโs strong growth trajectory, with revenue up 57% over the โฆSee details»
ElectroCore anticipates $30M 2025 revenue amid product line โฆ
13 hours ago electroCore is poised for continued growth in 2025, supported by its acquisition of NeuroMetrix and the expansion of its Truvaga and Quell product lines. With a revenue โฆSee details»
Reorganization of electroCore management team as Frank Amato โฆ
Dec 14, 2017 Basking Ridge, New Jersey: Frank Amato, previously Chief Operating Officer, has been appointed Chief Executive Officer of electroCore, the Merck-backed world leader in non โฆSee details»